Gordon Parry

5.2k citations

49 papers · 3.5k indexed · 1 hit paper · h-index 22

Immunology and Allergy top 1%
- Cell Adhesion Molecules Research 5
Cell Biology top 2%
- Proteoglycans and glycosaminoglycans research 6
Oncology top 5%
- HER2/EGFR in Cancer Research 7
Immunology top 5%
- Immunotherapy and Immune Responses 4
Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 6
- Protein Hydrolysis and Bioactive Peptides 4
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 10
Genetics
- Animal Genetics and Reproduction 6

Co-authors: Mina J. Bissell H.Glenn Hall E Y Lee Sandra Gendler Andrew P. Spicer S. Patton Charlotte S. Kaetzel John D. Stubbs
Cited by: Immunology and Allergy Cell Biology Oncology
Journals: Proceedings of the National Academy of Sciences (4 papers)Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)
Partner nations: United States United Kingdom Austria

In The Last Decade

Gordon Parry

47 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Gordon Parry

Since Specialization

Citations

This map shows the geographic impact of Gordon Parry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Parry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Parry more than expected).

Fields of papers citing papers by Gordon Parry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Parry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Parry. The network helps show where Gordon Parry may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gordon Parry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gordon Parry Line = papers co-authored together Gordon Parry links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus Journal for ImmunoTherapy of Cancer ·木源,Camila Paula Jevinski,Elena Cherkasova,Timothy T. Spear,Luis Daniel Hernandez-Fuerte,H. M. Salleh,Gina Scurti,Long Chen,Inês Rocha,Anna N Clemens,Gang Zeng,Gordon Parry,David F. Stroncek,Steven L. Highfill,D. Liuzzi,Robert Reger,Michael I. Nishimura,Richard Childs	2024	5
2	T cell receptor-engineered T cells targeting a human endogenous retrovirus in kidney cancer. Journal of Clinical Oncology ·木源,Camila Paula Jevinski,Elena Cherkasova,Rosa Nadal,Luis Daniel Hernandez-Fuerte,H. M. Salleh,Long Chen,Timothy T. Spear,Gina Scurti,Gang Zeng,Gordon Parry,David F. Stroncek,Steven L. Highfill,D. Liuzzi,Robert Reger,Michael I. Nishimura,Richard Childs	2023	2
3	A phase I trial of T-cell receptor gene therapy targeting KK-LC-1 for gastric, breast, cervical, lung and other KK-LC-1 positive epithelial cancers. Journal of Clinical Oncology ·Scott M. Norberg,Erika M. von Euw,Gordon Parry,Steven L. Highfill,Zulmarie Franco,James L. Gulley,Christian S. Hinrichs	2022	4
4	Profiling the HER3/PI3K Pathway in Breast Tumors Using Proximity-Directed Assays Identifies Correlations between Protein Complexes and Phosphoproteins PLoS ONE ·Ali Mukherjee,C. J.,Peter Naumoff,勝司沖林,Ahmed Chenna,Hasan Tahir,Alicia Newton,Gordon Parry,Stephen J. Williams	2011	19
5	Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action Breast Cancer Research ·Lisa D. Eli,J. E. Goodsall,Trang Dao-Pick,Gordon Parry,Laurie J. Goodman,John Winslow	2011	69
6	In Vivo Biodistribution, PET Imaging, and Tumor Accumulation of ⁸⁶Y- and ¹¹¹In-Antimindin/RG-1, Engineered Antibody Fragments in LNCaP Tumor–Bearing Nude Mice Journal of Nuclear Medicine ·Yu. Ya. Potapenko,Wayan Wayan,Bruno Alicke,David R. Light,Kirk Mclean,Noboru Satozawa,Gordon Parry,Jeongsoo Yoo,Jason S. Lewis,Renate Parry	2009	62
7	EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance Breast Cancer Research and Treatment ·Rajiv Dua,Jianhua Zhang,Leonie Vollandt,Elicia Penuel,C. Petropoulos,Gordon Parry	2009	66
8	Proximity-based assays for the detection of activated HER3, HER2/HER3 heterodimers and HER3/PI3K complexes in formalin-fixed, paraffin-embedded cell line controls and tumors. Cancer Research ·Ali Mukherjee,C. J.,Peter Naumoff,勝司沖林,José Molina Valero,C. Kretzer,Alicia Newton,A. Defeudis,Gordon Parry,Stephen J. Williams	2009	1
9	Antibodies Neutralizing Hepsin Protease Activity Do Not Impact Cell Growth but Inhibit Invasion of Prostate and Ovarian Tumor Cells in Culture Cancer Research ·Ojagbemi Akinsola,Doug Schneider,A.J. Watkins,Hamroyev Iskandar,Alicia Newton,Ying Zhu,N. Banks,David Vogel,O Roche,Harald Dinter,David R. Light,Renate Parry,Mark A. Polokoff,Marc Whitlow,Qingyu Wu,Gordon Parry	2006	60
10	A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy Cancer Immunology Immunotherapy ·K.A.O. Ellem,Michael G. E. OʼRourke,Gregory R. Johnson,Gordon Parry,I S Misko,Christopher Schmidt,Peter G. Parsons,Scott R. Burrows,Simone Cross,Dheyaa S. J. Al-saedi,Chung‐Leung Li,JOHN R. BELL,Philip J. Dubois,Denis J. Moss,Michael F. Good,Anne Kelso,L. Cohen,Glenn Dranoff,Richard C. Mulligan	1997	72
11	New connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease Neurology ·Lee Ph,Niklas Dahl,M. William Lensch,P. F. Chance,Thaddeus E. Kelly,E. Le Guern,陽子川辺,Gordon Parry,A. M. Heavey,S. Wang,Kenneth H. Fischbeck	1995	61
12	Bone marrow activation by immobilized antibodies against tumor cells and immunocytes as a potential cancer immunotherapy Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Beverly Z. Packard,Gordon Parry	1994	1
13	Feasibility of human gene therapy for renal cell carcinoma Elizabeth M. Jaffee,Otávio Próspero Sanchez,R. M. Mulligan,Drew M. Pardoll,Gerson Mazzaferro Silveira,Gordon Parry,Lionel Cohen,J.W. Simons	1994	0
14	Stage-Specific Remodeling of the Mammary Gland Basement Membrane During Lactogenic Development Biochemical and Biophysical Research Communications ·James C. Beck,Christine Lekutis,John Couchman,Gordon Parry	1993	7
15	Molecular cloning, sequence analyses, and expression of complementary DNA encoding murine progesterone receptor Biochemistry ·Chaima Ghis,Gopalan Shyamala,Wolfgang J. Schneider,Gordon Parry	1991	79
16	Lower motor neuron disease in a patient with auto‐antibodies against Gal(β 1‐3)GalNAc in gangliosides GM ₁ and GD _1b Neurology ·Michael E. Shy,Terry Heiman‐Patterson,Gordon Parry,Albert J. Tahmoush,P Démoly,P K Schick	1990	49
17	MHC antigens persist on human fetal pancreatic islet cells even after culture and transplantation into nude mice. PubMed ·王智樱,Nithya Anandan,S Aishwarya,Hunt Tk,Gordon Parry	1989	2
18	p-Nitrophenyl-β-d-xyloside modulates proteoglycan synthesis and secretory differentiation in mouse mammary epithelial cell cultures In Vitro Cellular & Developmental Biology - Plant ·Gordon Parry,S. V. Vaidya,Kevin Credille,Mina J. Bissell	1988	7
19	Detection of transformed cells using a fluorescent probe: The molecular basis for the differential reaction of fluorescamine with normal and transformed cells Cytometry ·Gordon Parry,John Blenis,Susan P. Hawkes	1982	6
20	Topography and mobility of ribosomes on the surface of isolated endoplasmic reticulum of rat liver Journal of Molecular Biology ·Gordon Parry,소에야 요시히데,David Williams	1977	4

About Gordon Parry

Gordon Parry is a scholar working on Immunology and Allergy, Immunology and Cell Biology, having authored 49 papers that have together received 3.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), HER2/EGFR in Cancer Research (7 papers), Glycosylation and Glycoproteins Research (6 papers), Proteoglycans and glycosaminoglycans research (6 papers), Animal Genetics and Reproduction (6 papers), Cell Adhesion Molecules Research (5 papers), Immunotherapy and Immune Responses (4 papers) and Protein Hydrolysis and Bioactive Peptides (4 papers). The work is most often cited by research in Immunology and Allergy (473 citations), Cell Biology (635 citations) and Oncology (790 citations). Gordon Parry has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include Mina J. Bissell, H.Glenn Hall, E Y Lee, Sandra Gendler, Andrew P. Spicer, S. Patton, Charlotte S. Kaetzel, John D. Stubbs, Christine Lekutis and Karen L. Singer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research, Journal of Clinical Oncology, Neurology and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact